$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 123.47 | 2 | 247 | 15,100 | 15.1 K to 15.1 K (-0.01 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 123.48 | 352 | 43,465 | 15,102 | 15.5 K to 15.1 K (-2.28 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 121.58 | 348 | 42,310 | 26,394 | 26.7 K to 26.4 K (-1.30 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 121.58 | 785 | 95,440 | 21,969 | 22.8 K to 22 K (-3.45 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 121.58 | 939 | 114,164 | 42,973 | 43.9 K to 43 K (-2.14 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 121.58 | 3,230 | 392,703 | 307,059 | 310.3 K to 307.1 K (-1.04 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 123.36 | 21,689 | 2,675,555 | 21,689 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 125.00 | 737 | 92,125 | 36,223 | 37 K to 36.2 K (-1.99 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 9,000 | 0 | 36,960 | 28 K to 37 K (+32.19 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 123.36 | 14,375 | 1,773,300 | 14,375 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 123.36 | 625 | 77,100 | 625 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 6,000 | 0 | 13,143 | 7.1 K to 13.1 K (+84.00 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 123.36 | 7,511 | 926,557 | 7,511 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 123.36 | 739 | 91,163 | 739 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 125.00 | 285 | 35,625 | 26,742 | 27 K to 26.7 K (-1.05 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,300 | 0 | 27,027 | 23.7 K to 27 K (+13.91 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 123.36 | 10,000 | 1,233,600 | 10,000 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 4,000 | 0 | 15,454 | 11.5 K to 15.5 K (+34.92 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 123.36 | 14,305 | 1,764,665 | 14,305 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 123.36 | 695 | 85,735 | 695 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Payment of Exercise | F | 125.00 | 469 | 58,625 | 18,992 | 19.5 K to 19 K (-2.41 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Grant | A | 0.00 | 6,000 | 0 | 19,461 | 13.5 K to 19.5 K (+44.57 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Option Exercise | A | 123.36 | 10,000 | 1,233,600 | 10,000 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 125.00 | 392 | 49,000 | 22,754 | 23.1 K to 22.8 K (-1.69 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Grant | A | 0.00 | 4,000 | 0 | 23,146 | 19.1 K to 23.1 K (+20.89 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 123.36 | 21,689 | 2,675,555 | 21,689 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 125.00 | 735 | 91,875 | 43,912 | 44.6 K to 43.9 K (-1.65 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Grant | A | 0.00 | 9,000 | 0 | 44,647 | 35.6 K to 44.6 K (+25.25 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 123.36 | 76,689 | 9,460,355 | 76,689 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 125.00 | 2,607 | 325,875 | 310,289 | 312.9 K to 310.3 K (-0.83 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 31,000 | 0 | 312,896 | 281.9 K to 312.9 K (+11.00 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 123.36 | 21,689 | 2,675,555 | 21,689 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 125.00 | 731 | 91,375 | 66,959 | 67.7 K to 67 K (-1.08 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 9,000 | 0 | 67,690 | 58.7 K to 67.7 K (+15.33 %) |
Feb 24 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 124.78 | 1,722 | 214,867 | 1,102,579 | 1.1 M to 1.1 M (-0.16 %) |
Feb 24 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 123.81 | 2,927 | 362,397 | 1,104,301 | 1.1 M to 1.1 M (-0.26 %) |
Feb 24 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 122.83 | 15,824 | 1,943,705 | 1,107,228 | 1.1 M to 1.1 M (-1.41 %) |
Feb 24 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 122.03 | 4,779 | 583,174 | 1,123,052 | 1.1 M to 1.1 M (-0.42 %) |
Feb 24 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 120.68 | 2,716 | 327,761 | 1,127,831 | 1.1 M to 1.1 M (-0.24 %) |
Feb 17 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 115.63 | 100 | 11,563 | 13,461 | 13.6 K to 13.5 K (-0.74 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 120.31 | 7 | 842 | 4,323 | 4.3 K to 4.3 K (-0.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 119.55 | 34 | 4,065 | 4,330 | 4.4 K to 4.3 K (-0.78 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 118.39 | 63 | 7,459 | 4,364 | 4.4 K to 4.4 K (-1.42 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 117.46 | 52 | 6,108 | 4,427 | 4.5 K to 4.4 K (-1.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 116.19 | 34 | 3,951 | 4,479 | 4.5 K to 4.5 K (-0.75 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 114.43 | 6 | 687 | 4,513 | 4.5 K to 4.5 K (-0.13 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 120.33 | 393 | 47,288 | 215,677 | 216.1 K to 215.7 K (-0.18 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 119.55 | 1,666 | 199,165 | 216,070 | 217.7 K to 216.1 K (-0.77 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 118.40 | 3,159 | 374,013 | 217,736 | 220.9 K to 217.7 K (-1.43 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 117.46 | 2,594 | 304,692 | 220,895 | 223.5 K to 220.9 K (-1.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 116.20 | 1,698 | 197,304 | 223,489 | 225.2 K to 223.5 K (-0.75 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 114.43 | 294 | 33,641 | 225,187 | 225.5 K to 225.2 K (-0.13 %) |
Feb 11 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 111.37 | 2,500 | 278,425 | 281,896 | 284.4 K to 281.9 K (-0.88 %) |
Apr 18 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 145.79 | 100 | 14,579 | 18,792 | 18.9 K to 18.8 K (-0.53 %) |
Apr 15 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 150.00 | 5,007 | 751,050 | 18,663 | 23.7 K to 18.7 K (-21.15 %) |
Apr 15 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Payment of Exercise | F | 147.34 | 103 | 15,176 | 13,040 | 13.1 K to 13 K (-0.78 %) |
Apr 13 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 136.98 | 4,000 | 547,920 | 60,470 | 64.5 K to 60.5 K (-6.20 %) |
Apr 08 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 140.90 | 2,161 | 304,485 | 23,670 | 25.8 K to 23.7 K (-8.37 %) |
Jan 21 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 122.66 | 100 | 12,266 | 13,561 | 13.7 K to 13.6 K (-0.73 %) |
Jan 14 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 123.81 | 2,500 | 309,525 | 284,396 | 286.9 K to 284.4 K (-0.87 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.24 | 24 | 3,342 | 4,519 | 4.5 K to 4.5 K (-0.53 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.37 | 57 | 7,887 | 4,543 | 4.6 K to 4.5 K (-1.24 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.71 | 116 | 15,974 | 4,600 | 4.7 K to 4.6 K (-2.46 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.25 | 1,214 | 169,043 | 225,481 | 226.7 K to 225.5 K (-0.54 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.37 | 2,843 | 393,371 | 226,695 | 229.5 K to 226.7 K (-1.24 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.71 | 5,746 | 791,274 | 229,538 | 235.3 K to 229.5 K (-2.44 %) |
Dec 17 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 136.99 | 100 | 13,699 | 13,661 | 13.8 K to 13.7 K (-0.73 %) |
Dec 09 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 139.72 | 2,500 | 349,300 | 286,855 | 289.4 K to 286.9 K (-0.86 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 148.49 | 424 | 62,960 | 1,310 | 1.7 K to 1.3 K (-24.45 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.57 | 34 | 5,018 | 4,716 | 4.8 K to 4.7 K (-0.72 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 146.96 | 68 | 9,993 | 4,750 | 4.8 K to 4.8 K (-1.41 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 145.96 | 94 | 13,720 | 4,818 | 4.9 K to 4.8 K (-1.91 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.58 | 1,737 | 256,339 | 235,284 | 237 K to 235.3 K (-0.73 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 146.95 | 3,395 | 498,900 | 237,021 | 240.4 K to 237 K (-1.41 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 145.96 | 4,672 | 681,940 | 240,416 | 245.1 K to 240.4 K (-1.91 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 150.00 | 100 | 15,000 | 1,130,547 | 1.1 M to 1.1 M (-0.01 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 149.21 | 1,465 | 218,587 | 1,130,647 | 1.1 M to 1.1 M (-0.13 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 148.10 | 5,628 | 833,487 | 1,132,112 | 1.1 M to 1.1 M (-0.49 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 147.50 | 2,000 | 294,993 | 1,137,740 | 1.1 M to 1.1 M (-0.18 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 146.00 | 550 | 80,298 | 1,139,740 | 1.1 M to 1.1 M (-0.05 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 145.13 | 500 | 72,563 | 1,140,290 | 1.1 M to 1.1 M (-0.04 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 147.15 | 1,000 | 147,149 | 1,140,790 | 1.1 M to 1.1 M (-0.09 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 146.25 | 1,700 | 248,625 | 1,141,790 | 1.1 M to 1.1 M (-0.15 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 145.28 | 2,700 | 392,264 | 1,143,490 | 1.1 M to 1.1 M (-0.24 %) |
Nov 24 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 144.12 | 12,325 | 1,776,330 | 1,146,190 | 1.2 M to 1.1 M (-1.06 %) |
Nov 17 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 134.03 | 100 | 13,403 | 13,690 | 13.8 K to 13.7 K (-0.73 %) |
Nov 17 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Sell | S | 136.08 | 1,200 | 163,299 | 19,146 | 20.3 K to 19.1 K (-5.90 %) |
Nov 17 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Sell | S | 135.37 | 1,621 | 219,438 | 20,346 | 22 K to 20.3 K (-7.38 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 128.53 | 2,500 | 321,325 | 289,355 | 291.9 K to 289.4 K (-0.86 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.96 | 18 | 2,483 | 4,912 | 4.9 K to 4.9 K (-0.37 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.16 | 36 | 4,938 | 4,930 | 5 K to 4.9 K (-0.72 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.85 | 32 | 4,347 | 4,966 | 5 K to 5 K (-0.64 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 134.76 | 62 | 8,355 | 4,998 | 5.1 K to 5 K (-1.23 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.95 | 34 | 4,554 | 5,060 | 5.1 K to 5.1 K (-0.67 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.70 | 8 | 1,062 | 5,094 | 5.1 K to 5.1 K (-0.16 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 128.96 | 6 | 774 | 5,102 | 5.1 K to 5.1 K (-0.12 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.98 | 932 | 128,595 | 245,088 | 246 K to 245.1 K (-0.38 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.15 | 1,809 | 248,097 | 246,020 | 247.8 K to 246 K (-0.73 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.85 | 1,573 | 213,693 | 247,829 | 249.4 K to 247.8 K (-0.63 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 134.76 | 3,138 | 422,878 | 249,402 | 252.5 K to 249.4 K (-1.24 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.95 | 1,666 | 223,154 | 252,540 | 254.2 K to 252.5 K (-0.66 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.70 | 392 | 52,018 | 254,206 | 254.6 K to 254.2 K (-0.15 %) |
Nov 12 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 128.96 | 294 | 37,914 | 254,598 | 254.9 K to 254.6 K (-0.12 %) |
Oct 23 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 125.00 | 2,000 | 250,006 | 35,855 | 37.9 K to 35.9 K (-5.28 %) |
Oct 16 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 131.86 | 100 | 13,186 | 13,790 | 13.9 K to 13.8 K (-0.72 %) |
Oct 15 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 131.50 | 2,500 | 328,750 | 291,855 | 294.4 K to 291.9 K (-0.85 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.81 | 1 | 138 | 5,108 | 5.1 K to 5.1 K (-0.02 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 136.60 | 34 | 4,645 | 5,109 | 5.1 K to 5.1 K (-0.66 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.73 | 10 | 1,357 | 5,143 | 5.2 K to 5.1 K (-0.19 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 134.32 | 25 | 3,358 | 5,153 | 5.2 K to 5.2 K (-0.48 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.94 | 83 | 11,034 | 5,178 | 5.3 K to 5.2 K (-1.58 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.26 | 43 | 5,687 | 5,261 | 5.3 K to 5.3 K (-0.81 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.81 | 99 | 13,643 | 254,892 | 255 K to 254.9 K (-0.04 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 136.60 | 1,695 | 231,540 | 254,991 | 256.7 K to 255 K (-0.66 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.73 | 490 | 66,506 | 256,686 | 257.2 K to 256.7 K (-0.19 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 134.32 | 1,225 | 164,539 | 257,176 | 258.4 K to 257.2 K (-0.47 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.94 | 4,193 | 557,414 | 258,401 | 262.6 K to 258.4 K (-1.60 %) |
Oct 07 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 132.26 | 2,102 | 278,000 | 262,594 | 264.7 K to 262.6 K (-0.79 %) |
Sep 29 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 145.23 | 100 | 14,523 | 13,890 | 14 K to 13.9 K (-0.71 %) |
Sep 09 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 164.01 | 460 | 75,445 | 294,355 | 294.8 K to 294.4 K (-0.16 %) |
Sep 09 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 162.86 | 2,040 | 332,234 | 294,815 | 296.9 K to 294.8 K (-0.69 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.33 | 37 | 6,228 | 5,304 | 5.3 K to 5.3 K (-0.69 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.32 | 21 | 3,514 | 5,341 | 5.4 K to 5.3 K (-0.39 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 166.36 | 24 | 3,993 | 5,362 | 5.4 K to 5.4 K (-0.45 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 165.26 | 57 | 9,420 | 5,386 | 5.4 K to 5.4 K (-1.05 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 164.50 | 57 | 9,377 | 5,443 | 5.5 K to 5.4 K (-1.04 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.34 | 1,857 | 312,602 | 264,696 | 266.6 K to 264.7 K (-0.70 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.33 | 1,081 | 180,882 | 266,553 | 267.6 K to 266.6 K (-0.40 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 166.36 | 1,169 | 194,472 | 267,634 | 268.8 K to 267.6 K (-0.43 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 165.27 | 2,846 | 470,347 | 268,803 | 271.6 K to 268.8 K (-1.05 %) |
Sep 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 164.51 | 2,851 | 469,018 | 271,649 | 274.5 K to 271.6 K (-1.04 %) |
Aug 31 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.87 | 425 | 71,345 | 1,734 | 2.2 K to 1.7 K (-19.69 %) |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 166.62 | 17,149 | 2,857,366 | 48,251 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 166.62 | 67 | 11,164 | 533 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 59.13 | 50,636 | 2,994,107 | 72,673 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 59.13 | 403 | 23,829 | 1,288 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 46.83 | 89,098 | 4,172,459 | 106,632 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 46.83 | 1,618 | 75,771 | 2,652 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | J | 11.48 | 6,896 | 79,166 | 6,895 | |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 177.82 | 2,500 | 444,550 | 296,855 | 299.4 K to 296.9 K (-0.84 %) |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Payment of Exercise | F | 181.48 | 7,743 | 1,405,200 | 299,355 | 307.1 K to 299.4 K (-2.52 %) |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 177.82 | 4,000 | 711,280 | 37,855 | 41.9 K to 37.9 K (-9.56 %) |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Sell | S | 177.82 | 500 | 88,910 | 58,602 | 59.1 K to 58.6 K (-0.85 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 177.51 | 21 | 3,728 | 11,401 | 11.4 K to 11.4 K (-0.18 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 177.82 | 1,309 | 232,766 | 11,422 | 12.7 K to 11.4 K (-10.28 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 181.48 | 1,956 | 354,975 | 23,686 | 25.6 K to 23.7 K (-7.63 %) |